Author of the publication

Translating expression profiling into a clinically feasible test to predict neuroblastoma outcome.

, , , , , , , , and . Clin Cancer Res, 13 (5): 1459--1465 (March 2007)
DOI: 10.1158/1078-0432.CCR-06-2032

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling., , , , , , , , , and 2 other author(s). Oncogene, 24 (53): 7902--7912 (November 2005)High ALK receptor tyrosine kinase expression supersedes ALK mutation as a determining factor of an unfavorable phenotype in primary neuroblastoma., , , , , , , , , and 8 other author(s). Clin Cancer Res, 17 (15): 5082--5092 (August 2011)Logic Learning Machine creates explicit and stable rules stratifying neuroblastoma patients., , , , , , , , , and . BMC Bioinform., 14 (S-7): S12 (2013)Accurate outcome prediction in neuroblastoma across independent data sets using a multigene signature., , , , , , , , , and 10 other author(s). Clin Cancer Res, 16 (5): 1532--1541 (March 2010)Translating expression profiling into a clinically feasible test to predict neuroblastoma outcome., , , , , , , , and . Clin Cancer Res, 13 (5): 1459--1465 (March 2007)Neuroblastoma signalling models unveil combination therapies targeting feedback-mediated resistance., , , , , , , , , and 5 other author(s). PLoS Comput. Biol., (2021)